Physician profile
Gregory V Schimizzi
NPI 1205323417
$25,239.09
in general payments reported to CMS, 2019-2025
11 companies · $4,260 in 2025
The $4,260 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $265 · 2023: $3,081 · 2024: $18K · 2025: $4,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Food and Beverage: $7,162 · Travel and Lodging: $2,812 · Education: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Food and Beverage | $7,162.23 |
| Travel and Lodging | $2,812.10 |
| Education | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,149.99 | 2024-2025 | |
| Smith+Nephew, INC. | $5,127.42 | 2023-2025 | Trigen Intertan, Evos |
| Depuy Synthes Sales INC. | $2,301.88 | 2024-2025 | Na, Tfn-Advance, Lcp |
| Globus Medical, INC. | $2,028.47 | 2024-2025 | Distal Femur Plate System, Anthem, Evo Retrograde |
| Stryker Corporation | $1,814.07 | 2022-2025 | Axsos, Gamma, T2 Alpha |
| Medical Device Business Services, INC. | $1,770.57 | 2025 | Na |
| Lightbody Medical Technologies INC | $1,317.73 | 2024-2025 | |
| Medinc of Texas | $458.44 | 2023-2025 | |
| Si-Bone, INC. | $166.41 | 2025 | |
| Osteocentric Technologies, INC. | $58.99 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| My01 INC. | $45.12 | 2024 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Schimizzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.